Search

everythinglearnresearchcommunity

for

Search:↓

Hair transplants can effectively treat hair loss from CCCA in African American women if there's no inflammation.

Hair loss in black women needs more research, early intervention, and community education.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

4-META resin heals skin wounds faster and better than cyanoacrylate.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.

Infrared thermography, especially with dermoscopy, improves accuracy in diagnosing active hair loss due to inflammation.

Artificial hair implantation using scaffolds is possible and PHDPE is more biocompatible than ePTFE.

High-dose radiation speeds up aging in skin stem cells.

Ice-skating athletes often have skin problems due to cold, infections, and inflammation, needing careful treatment and prevention.

Conflicting findings in androgenic alopecia are likely due to biopsy location, hair diameter diversity, and hair follicle miniaturization.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Some women with common hair loss may develop permanent hair loss.

Vitamin A might be a safe extra treatment for dogs with sebaceous adenitis, but more research is needed to prove its effectiveness.

A rabbit with sebaceous adenitis was effectively treated with ciclosporin and medium-chain triglycerides.

A mother and daughter have a rare genetic hair loss disorder with no effective treatment.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Female pattern hair loss diagnosis is challenging and should use dermoscopy and histopathology instead of pattern recognition, as hormones may not always be the cause.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

Stem cell therapies could be a promising alternative for hair loss treatment, but more research is needed to understand their full potential and safety.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

New microneedle treatment with growth factors and a hair loss drug shows better and faster hair growth results than current treatments.

Finasteride may help treat autism by reducing inflammation and oxidative stress.

Inflammation and fibrosis are not significantly different in pattern hair loss compared to controls.

The document concludes that diagnosing hair loss requires evaluating multiple histological features, as no single feature is definitive on its own.